Recent Articles

U.S. Debut of Biosimilar Drugs Threatens Major Biotechs

The introduction of biosimilar drugs will change the biotech landscape ... especially for these three names. More 

10 Healthcare Stocks Taking Aim at Cancer

Amgen, Inc. (NASDAQ:AMGN), Celgene Corporation (NASDAQ:CELG), Inovio Pharmaceuticals Inc. (NASDAQ:INO) and several other healthcare stocks are cancer medicine plays worth a look. More 

Will Lower Oil Mean Higher Q4 Earnings?

With Q4 earnings season upon us, better-than-expected gains from companies based partly or mostly on lower oil prices may be just the salve the market needs to regain some traction. More 

Add Roche to Your List of Ebola Stocks, But …

Ebola stocks have doled out some big gains to savvy traders this year, but investors looking for Roche (RHHBY) to do the same may want to rethink their expectations. More 

Gilead Stock Will Rise on Sovaldi® Sales

Gilead's breakthrough Hepatitis C drug, Sovaldi®, will drive revenue and profits for the rest of 2014 and into 2015. More 

Roche Proves You Can’t Judge a Book by Its Cover

Roche stock may not be an NYSE or NASDAQ-listed equity, but when you look at the details, RHHBY is plenty investment-worthy. More 

3 Huge Healthcare Trends Can Fatten Your Portfolio

Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities More